Fig. 3
From: Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Fab sialylation level of total IgG and auto-antibodies following B cell depletion therapy. A Percentage of total IgG that is Fab sialylated at 0, 6, and 12 months after start of B cell depletion therapy. In RA (red), PV (yellow), AAV (green), and MS (pink). Connected dots represent a patient. B Percentage of auto-antibodies that is Fab sialylated at 0, 6, and 12 months following B cell depletion therapy. For RA; anti-CCP (red), PV; anti-Dsg3 (yellow), and AAV; anti-PR3 (green). Statistical differences were determined using a Wilcoxon matched-pairs signed rank test. *p < 0.05, **p < 0.01, ***p < 0.001.
